| Outgoing Relation(s) |
| EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) is a EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor (CHEBI:76878) |
| Incoming Relation(s) |
| (R)-Fasnall (CHEBI:145533) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| (S)-Fasnall (CHEBI:145534) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| trans-rhaponticin (CHEBI:8824) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| C75 (CHEBI:189865) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| CT2108A (CHEBI:65678) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| CT2108B (CHEBI:65679) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| Cutin-1 (CHEBI:133750) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| Fasnall (CHEBI:145520) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| luteolin (CHEBI:15864) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| NPD6433 (CHEBI:195528) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| orlistat (CHEBI:94686) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| platencin (CHEBI:68241) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
| platensimycin (CHEBI:68236) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476) |
